Accrued Expenses

9 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Accrued Expenses

Accrued expenses are composed of the following at December 31, 2018 and March 31, 2018:

	December 31,		March 31,
	2018		2018
Accrued AV-101 clinical trial, development
and related expenses	$	759,300	$	176,600
Accrued professional services		59,000		27,000
All other		8,800		2,700
	$	827,100	$	206,300